DavidG.TelanderMDPhD
Ophthalmology • Sacramento, CARetinal Disease
Retinal Consultants of Sacramento; Clinical Professor at UC Davis
Dr. Telander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3939 J St
Ste 106
Sacramento, CA 95819Phone+1 916-454-4861Fax+1 916-454-3603
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Surgical Retina and Vitreous, 2003 - 2005
University of MinnesotaResidency, Ophthalmology, 2000 - 2003
Hennepin HealthcareInternship, Transitional Year, 1999 - 2000
Stanford UniversityBAS, Biology and History, 1986 - 2000- University of Minnesota Medical SchoolClass of 1999
Certifications & Licensure
CA State Medical License 2003 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD) Start of enrollment: 2009 Aug 01
- Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration Start of enrollment: 2015 Apr 01
Publications & Presentations
PubMed
- 6 citationsMETformin for the MINimization of Geographic Atrophy Progression (METforMIN): A Randomized Trial.Liangbo Linus Shen, Jeremy D Keenan, Noor Chahal, Abu Tahir Taha, Jasmeet Saroya
Ophthalmology Science. 2023-12-04 - 5 citationsMyo/Nog cells expressing muscle proteins are present in preretinal membranes from patients with proliferative vitreoretinopathyJacquelyn Gerhart, Nathan Morrison, Lindsay Gugerty, David G. Telander, Arturo Bravo-Nuevo
Experimental Eye Research. 2020-05-29 - 4 citationsComparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone AcetonideZeljka Smit-McBride, Elad Moisseiev, Sara P. Modjtahedi, David G. Telander, Leonard M. Hjelmeland
Journal of Ophthalmology. 2016-06-27
Press Mentions
Clinical Trial in Dry-AMD with the Opening of Two Additional U.S. SitesMay 24th, 2018
Dr. David Telander Named Among the Top 1% of Doctors in the NationMarch 10th, 2016
Grant Support
- Novel Therapies To Prevent Blindness Caused By Proliferative VitreoretinopathyNational Eye Institute2010–2012
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
